Pacific Trade Invest NZ invites you to an important webinar on the FMCG industry in New Zealand. This will be of great ...

But 15 months on from La Roja lifting the trophy in Australia and New Zealand, how much has really changed for them ...

Leveraging FB Dermatology's sales and distribution networks in Europe, Australia and New Zealand to launch the DermaKB ® product ... myelofibrosis in adults who have moderate to severe anemia GSK ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

New Zealand’s banking landscape faces significant changes as new players target different segments, potentially disrupting ...

GlaxoSmithKline is under pressure from shareholders ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

New Zealand claimed a statement victory for new coach Scott Robertson as Damian McKenzie helped kick them to a 23-13 win over ...